Fundraising FoxSwan Genomics
1 known investors
Find your way into Swan Genomics
Sign up to see every warm intro you have to Swan Genomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Swan Genomics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SWAN Genomics is developing a DNA sequencing platform based on plasmonic nanoantenna technology that detects single molecules on native genetic material without amplification, preserving epigenetic information like methylation in a single run. Its in-development Gen 1 platform combines an instrument, reagents, and flowcell aimed at applications spanning clinical diagnostics and genomics research.
Founders & leadership
LL
Lawrence LeeCo-Founder & CEO
MH
Min HuangCo-Founder & Director of R&D
BS
Brock SiegelCo-Founder & Board
WH
William HyunCo-Founder & Board
MM
Morassa MohseniSVP Product, Commercial & Operations
Investors · 1
Frequently asked questions
- What does Swan Genomics do?
- SWAN Genomics is developing a DNA sequencing platform based on plasmonic nanoantenna technology that detects single molecules on native genetic material without amplification, preserving epigenetic information like methylation in a single run. Its in-development Gen 1 platform combines an instrument, reagents, and flowcell aimed at applications spanning clinical diagnostics and genomics research.
- Who are Swan Genomics's investors?
- Swan Genomics's investors include In-Q-Tel.